Wax-Matrix Tablet for Time-Dependent Colon-Specific Delivery System of Sophora Flavescens Aiton: Preparation and In Vivo Evaluation

REFERENCES

• Q. R. Cao, T. W. Kim, and B. J. Lee. (2007). Photoimages and the release characteristics of lipophilic matrix tablets containing highly water-soluble potassium citrate with high drug loadings. Int. J. Pharm. 339:19–24.
   PubMed Web of Science ®Google Scholar
• E. Carceller, J. Salas, M. Merlos, M. Giral, R. Ferrando, I. Escamilla, J. Ramis, J. Garcia-Rafanell, and J. Forn. (2001). Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. J. Med. Chem. 44:3001–3013.
   PubMed Web of Science ®Google Scholar
• G. Cheng, F. An, M. J. Zou, J. Sun, X. H. Hao, and Y. X. He. (2004). Studies on the diclofenac sodium time-dependent and 5-aminosalicylic acid pH-dependent oral colon-specific drug delivery systems. WJG 12:1769–1774.
   Google Scholar
• M. K. Chourasia, and S. K. Jain. (2003). Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 6:33–66.
   PubMed Web of Science ®Google Scholar
• U. Conte, P. Colombo, A. La Manna, A. Gazzaniga, M. E. Sangalli, and P. Giunchedi. (1989). A new ibuprofen pulsed release oral dosage form. Drug Dev. Ind. Pharm. 15 (14–16):2583.
   Web of Science ®Google Scholar
• T. Y. Fan, S. L. Wei, W. W. Yan, D. B. Chen, and J. Li. (2001). An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J. Control. Release 77:245–251.
   PubMed Web of Science ®Google Scholar
• A. Gazzaniga, P. Iamartino, G. Maffione, and M. E. Sangall. (1994). Oral delayed release system for colonic specific delivery. Int. J. Pharm 108:77–84.
   Web of Science ®Google Scholar
• V. K. Gupta, T. E. Beckert, and J. C. Price. (2001). A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int. J. Pharm. 213 (1–2):83–91.
   PubMedGoogle Scholar
• M. Halsas, J. Hietala, P. Veski, H. Jurjenson, and M. Marvola. (1999). Morning versus evening dosing of ibuprofen using conventional and time controlled release formulations. Int. J. Pharm. 189:179–185.
   PubMed Web of Science ®Google Scholar
• M. Halsas, T. Penttinen, P. Veski, H. Jurjenson, and M. Marvola. (2001). Time-controlled release pseudoephedrine tablets: Bioavailability and in vitro/in vivo correlations. Pharmazie 56:718–723.
   PubMed Web of Science ®Google Scholar
• W. M. Jeffery, and H. F. Hernry. (1996). Mathematical comparision of dissolution profiles. Pharm. Tech. 20:64–74.
   Google Scholar
• M. Z. Khan, Z. Prebeg, and N. Kurjakovic. (1999). A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J. Control. Release 58:215–222.
   PubMed Web of Science ®Google Scholar
• M. Z. Khan, H. P. Stedul, and N. Kurjakovic. (2000). A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev. Ind. Pharm. 26:549–554.
   PubMed Web of Science ®Google Scholar
• R. Kinget, W. Kalala, L. Vervoort, and G. van den Mooter. (1998). Colonic drug targeting. J. Drug Target. 6:129–149.
   PubMed Web of Science ®Google Scholar
• K. Krogars, J. Heinamaki, J. Vesalahti, M. Marvola, O. Antikainen, and J. Yliruusi. (2000). Extrusion-spheronization of pH-sensitive polymeric matrix pellete for possible colonic drug delivery. Int. J. Pharm. 199:187–194.
   PubMed Web of Science ®Google Scholar
• H. Liu, X.-G. Yang, S.-F. Nie, L.-L. Wei, L.-L. Zhou, H. Liu, R. Tang, and W.-S. Pan. (2007). Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int. J. Pharm 332:115–124.
   PubMed Web of Science ®Google Scholar
• M. Liu, X. Y. Liu, and J. F. Cheng. (2003). Advance in the pharmacological research on matrine. China J. Chinese Materia Medica 28:801–804.
   Google Scholar
• Z. R. Li. (2003). Pharmacological and clinical advances of oxymatrine. West China J. Pharm. Sci. 18:435–437.
   Google Scholar
• M. Muraoka, Z. P. Hu, T. Shimokawa, S. I. Sekino, R. E. Kurogoshi, Y. Kuboi, Y. Yoshikawa, and K. Takada. (1998). Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J. Control. Release 52:119–129.
   PubMed Web of Science ®Google Scholar
• F. Pozzi, P. Furlani, A. Gazzaniga, S. S. Davis, and I. R. Wilding. (1994). The time clock system: A new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Release 31:99.
   Web of Science ®Google Scholar
• S. S. Rao, and W. A. Ritschel. (1992). Development and in vitro/in vivo evaluation of a colonic release capsule of vasopressin. Int. J. Pharm. 86:35–41.
   Web of Science ®Google Scholar
• V. R. Sinha, and R. Kumria. (2001). Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 224:19–38.
   PubMed Web of Science ®Google Scholar
• D. Soodabeh, H. Jalal, and K. Abbas. (1999). Release of 5-ASA from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J. Control. Release 58:279–287.
   PubMed Web of Science ®Google Scholar
• K. Takada. (1997). Controlled-release preparations. United States Patent: 5,637,319 (1225 of 2331), 7 10.
   Google Scholar
• H. Tozaki, T. Fujita, T. Odoriba, A. Terabe, S. Okabe, S. Muranishi, and A. Yamamoto. (1999). Validation of a pharmacokinetic model of colon specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzene-sulphonic acid-induced colitis in rats. J. Pharm. Pharmacol. 51:1107–1112.
   PubMed Web of Science ®Google Scholar
• S. Wang, G. Wang, X. Li, J. Sun, R. Ma, and L. Sheng. (2005). Simultaneous determination of oxymatrine and its active metabolite matrine in dog plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 817 (2):319–325.
   PubMed Web of Science ®Google Scholar
• P. J. Watts, and L. Lllum. (1997). Colonic drug delivery. Drug Dev. Ind. Pharm. 23:893–913.
   Web of Science ®Google Scholar
• J. Xia, and C. Liu. (2000). The statistical evaluation and analysis of in vitro dissolution of solid preparation. J. Chinese Pharm. 35:345–349.
   Google Scholar
• L. Yang, J. S. Chu, and J. A. Fix. (2002). Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int. J. Pharm. 235:1–15.
   PubMed Web of Science ®Google Scholar
• Y. Yonezawa, S. Ishida, and H. Sunada. (2005). Release from or through a wax matrix system. VI. Analysis and prediction of the entire release process of the wax matrix tablet. Chem. Pharm. Bull. 53:915–918.
   PubMed Web of Science ®Google Scholar